Multicentre, randomised, open label study comparing a 'scheduled steroid reduction strategy' versus a free steroid reduction strategy (physician's usual practice for reducing steroids) in patients with active RA [rheumatoid arthritis] treated with Humira [adalimumab] 40 mg EOW [every other week] + MTX [methotrexate] during 9 months
Phase of Trial: Phase IV
Latest Information Update: 23 Apr 2007
At a glance
- Drugs Adalimumab; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 20 Nov 2005 New trial record.